He aha nā kolo o nā methyl etil pyridinol no?

ʻAleo ka pīkī, ʻaʻohe ʻāpana a ʻulaʻula paha.

Nā mea kūʻai: ka hoke hydrochloric 0.1 M hoʻonā - a i ka pH 2.5-3.5, wai d / i - a hiki i ka 1 ml.

1 ml - mau pahu būlima (5) - pūpū blister (1) - nā pā o ka pahu paʻi.
1 ml - mau pahu būlima (5) - pūpū blister (2) - nā pā o ka pahu paʻi.
1 ml - mau pahu ʻaʻa (5) - nā pā o ka pahu paʻi.
1 ml - mau pahu ʻaʻa (10) - nā pā o ka pahu paʻi.

Ka hana lāʻau lapaʻau

ʻO Angioprotector, hoʻemi i ka hiʻu o ka pā vascular, kahi mea pale i nā kaʻawale lāʻau radical, antihypoxant a me antioxidant.

Hoʻēmi i ka nānā ʻana i ke koko a me ka hōʻuluʻulu ʻana o ka platelet, hoʻonui i nā ʻike o ka nucleotides cyclic (cAMP a me cGMP) i loko o nā platelets a me ka lolo, ua loaʻa ka hana fibrinolytic, e hoʻemi ana i ka mana o ka pā vascular a me ka hopena o ka hemorrhage, paipai i kā lākou resorption. Hoʻonui ia i nā moku coronary, i ka manawa koʻikoʻi o ka infarction myocardial e hoʻohālikelike i ka nui o ka maka o ka fokus o ka nekrosis, e hoʻomaikaʻi i ka hiki ʻana o ka puʻuwai a me nā hana o kāna kaʻina. I ka piʻi nui o ke koko he hopena hypotensive. I loko o nā pilikia o ka ischemic disorders o ka cerebral circulation e hōʻemi ana i ka nui o nā hōʻailona neurological, hoʻonui i ka pale kino i ka hypoxia a me ischemia.

ʻO ia nā mea he retinoprotective, mālama i ka retina mai nā hopena ʻino o ka mālamalama kiʻekiʻe, e hoʻolalelale ʻana i nā hōʻiho ʻana o ka ʻōpū intraocular, hoʻomaikaʻi i ka microcirculation maka.

Hōʻikeʻike i nā lāʻau lapaʻau

Ma kahi ʻāpana o nā ululāʻau paʻakikī: nā hopena o ka ulia o ka cerebrovascular o ke ʻano ischemic a hemorrhagic, hōʻeha ke poʻo, ka wā kūpono o ka epi- a me ka hematomas subdural, kaʻi myocardial akarā, ka mālama ʻana i ka ulia o ka reperfusion, kūmau i ka angina pectoris.

Subconjunctival a me hemorrhage intraocular, angioretinopathy (me ka helu ʻana i ka maʻi diabetes), dystrophy chorioretinal (me ke ʻano o ka atherosclerotic kumu), keratitis dystrophic, thrombosis retinal vascular, hoʻopiʻi o ka myopia, mālama i ka kornea (i ka wā e pili ana i ka nānā aku) a me ka retina o ka maka ka māmā ikaika (laser a me ka lā o ka lā, me ka laser-coagulation), trauma, hoʻāhu a me ka puhi ʻana o ka kornea, cataract (me ka pale ʻana i nā poʻe ma luna o 40), ka hōʻiliʻili o ka maka, ke ʻano ma hope o ka hana no ka r laucoma me ka detachment choroid.

Ka hoʻoponopono ʻia ʻana

I loko o ka neurology a me ka cardiology - iv drip (20-40 mau hāʻule / min), 20-30 ml o kahi 3% hopena (600-900 mg) 1-3 mau lā i kahi lā no 5-15 mau lā (ma mua o ka inu ʻana o ka lāʻau ma 200 ml o 0.9% hopena o NaCl a i ʻole nā ​​5% hoʻonā dextrose. ʻO ke lōʻihi o ka mālama ʻana ma ke ala o ka maʻi. Ma hope aku, huli lākou i ka hoʻokele intramuscular - 3-5 ml o kahi hopena o 3% 2-3 mau manawa i ka lā no 10-30 mau lā.

I kahi ophthalmology - subconjunctival a parabulbar paha, 1 manawa i kēlā me kēia lā a i kēlā me kēia lā. ʻO Subconjunctival - 0.2-0.5 ml o ka hopena o 1% (2-5 mg), parabulbar - 0.5-1 ml o 1% kūleʻa (5-1 mg). ʻO ka lōʻihi o ka mālamaʻana he 10-30 mau lā, hiki nō ke hoʻopaʻi hou i ka papa i nā manawa he 2-3 i ka makahiki.

Inā pono, ʻo retrobulbar i ka 0.5-1 ml o ka hopena o 1% 1 manawa i ka lā no 10-15 lā.

No ka pale ʻana i ka retina i ka wā coagulation laser (me ka hoʻopau ʻana a me ka luku ʻana i ka koikoi o nā kani ʻana) - parabulbar a i ʻole retrobulbar 0.5-1 ml o 1% hopena 24 hola a me 1 hola ma mua o ka coagulation, a laila ma nā dosis like (0.5 ml kēlā) ʻO ka 1% hoʻoponopono) 1 manawa i ka lā no 2-10 lā.

Inoa kālepa

I ka pūnaewele māhele hoʻoili ʻia, kapa ʻia nā ʻōmaka maka e kapa ʻia ʻo Emoxipin, me ka hana nui o ka methylethylpyridinol (methylethylpiridinol). ʻO kona paʻa i ka hāleʻa he 1%, i.e., 1 ml o ka lāʻau lapaʻau he 10 mg o ka mea nui.

Loaʻa nā hāʻule ʻana o nā maka i ka kirika, i hoʻolako ʻia me kahi pūheo, nā bolo i piha me ka wai ʻōmaʻomaʻo māmā. ʻO ka nui o kēlā me kēia he 5 a 10 ml ranei. Hoʻopili ʻia nā hue ma nā pahu pepa me nā ʻōlelo kikoʻī i hoʻopili ʻia.

ʻO kahi hoʻohālikelike o kēia mau hāʻule he Emoxy-Optic.

Loaʻa ka Methylethylpyridinol i loko o 1 ml ampoules. Hoʻohana ʻia kēia ʻano o ka lāʻau lapaʻau e mālama i nā maʻi maka a hiki ke lawelawe ʻia ma ka subcutaneously (lalo haʻahaʻa o ka maka) a i ʻole komo i loko o ka orbit o ka maka (ma lalo o ka hapa o ka eyeball). Hoʻohana ʻia kēia mau ala o ka hoʻokele lāʻau i ka hoʻomānoʻi laser.

Wahi a nā ʻōlelo kuhikuhi, hiki ke mālama ʻia ka maka o ka maka iā Emoxipin ma ka lōʻihi ʻole aʻe ma mua o + 25 ° C no 2 mau makahiki, a ma hope o ka wehe ʻana - ʻaʻole iʻoi aʻe ma mua o 30 mau lā. E mālama ʻia ka wahi e mālama ai mai ka lohi ʻana mai a hiki i ka hiki ʻana o nā keiki liʻiliʻi.

Nā ʻōkuhi no ka hoʻohana: nā hōʻailona a me nā contraindications

Hoʻohana ʻia nā maka ʻo Emoksipin e mālama i ka pālahalaha o nā maka o ka maka, hiki nō i kā lākou hoʻohana ke hoʻohana pono i prophylactic:

• Na Mīleau Diabetic - kahi pane o ka pathology me ke ala lōʻihi o ka maʻi, i hōʻike ʻia ma nā palua o nā kīʻaha koko,
• Glaucoma - ʻike maka ʻia me ka piʻi pinepine ʻana a i ʻole mau i ka hoʻoikaika intraocular,
• Myopia - myopia, i ka wā e hele ai ke kukui i ke kāla ʻana i ka maka ma kahi manawa me ka hiki ʻole o ka retina. ʻO ke hopena, ʻaʻole ka mea e hoʻokaʻawale i nā mea i kahi lōʻihi.
• Hypermetropia - kaikai o ka wili, ka aoao o ka myopia. ʻIke maikaʻi ka mea maʻi i ka mamao, a kokoke i nā mea e loaʻa nā ʻōlaʻi pōkole.
• He kuni nā maka - ua hōʻino i ka ʻili i waho ma muli o ka hōʻike kemu, kiʻekiʻe t, radiation hihiu, vapors.

Heluhelu hou e pili ana i ka maʻi o ka glaucoma ma aneʻi.

ʻO Methylethylpyridinol kahi mea hana pono i ka mālamaʻana i nā kaʻina maʻi i nā membranes ocular o waho, me nā hemorrhages post-traumatic, a me nā hoʻopiʻi o ka conjunctivitis.

Hōʻalo ka hana hoʻohālikelike o ka hoʻohana ʻana i ka instillation ma kēlā me kēia maka 1 hāʻule i nā manawa 2-3 i ka lā. ʻO ka manawa maʻamau o ka mālamaʻana he 3-10 lā. Eia nō naʻe, e like me ka mea i kuhikuhi ai e ke kauka, hiki ke hoʻonui ʻia i ka papa hana a hiki i 1 mahina. ʻO ka hoʻomaikaʻi ʻana i ka pono o ka mālama ʻia e loaʻa ana ma o ka nānā ʻana i kekahi mau kānāwai maʻalahi:

• E holoi holoi i nā lima me ka umauma ma mua a ma hope o ke kaʻina hana,
• Ma mua o ka hoʻohana ʻana i ka dropper, e nānā e ʻike inā aia kekahi mau lua i ka hope e hiki ʻole ai ke hōʻeha i ka maka,
• Ke hoʻokomo nei i ka lepa, mai hoʻopā i ka dropper i ka ua o ka maka.
• Ma hope o ke kaʻina hana, e hoʻopili i nā maka, a hoʻoneʻe i nā umu i ʻike ʻia me ka lole pale.
• Wehe i nā lono pili ma mua o ke hoʻoilo ʻana i 15 mau minuke. , aahuahu ole ia mamua o 15 mau minuke. ma hope o ke kaʻina hana.

Hiki iā ʻoe ke heluhelu i ka kikokikona no ka nānā ʻana o ka maka ma aneʻi.

I ka wā o ka mālama ʻana, hiki ke hoʻopihapiha ʻia ka ʻike, no laila, nā poʻe e alakaʻi i nā hana e koi ana i ka nui o ka makaʻala e hana i kahi hoʻomaha.

Nā Hoʻohui

Aia ka papa inoa o nā contraindications no Emoxipin me ka liʻiliʻi loa o nā mea, me nā mea āpau e pili ana i nā pāpā āpau i pili pinepine ʻia i nā lā āpau.

Ua pāpā ʻia ka hoʻohana ʻana o ka maka o ka maka o ka methylethylpyridinol ma ke alo o kēia mau ʻano:

• ʻO ka hypersensitivity i ka mea ikaika a me nā mea ʻē aʻe,
• ʻO ka hala ahonui ʻaʻole iʻoi aku ma mua o 18 mau makahiki
• ʻO ka wā e hoʻohua ai a hānai i ke keiki.

Pono ka mālama nui ʻana i nā maʻi i nā maʻi me ka makemake e hoʻohālikelike i nā maʻi kūlohelohe, ʻoi loa ma ka hoʻomaka ʻana o ka mālama ʻana. Inā aia kahi mau leʻaleʻa e nalowale nei ma luna o nā kaʻina hana, pono e hoʻokaʻawale ʻia ka lāʻau lapaʻau a loaʻa pono nā ʻōlelo lapaʻau hou.

I ka wā hāpai

Ka wā gestational (manawa gestation) - kekahi o nā kuleana i ke ola o kēlā me kēia wahine. Pono kekahi lāʻau lapaʻau i ka wā o ka hapai ʻana, no ka mea aia mau ka liʻiliʻi o ka liʻiliʻi o ka hoʻopiʻi ʻana i ka hopena maikaʻiʻole i ka wahine hāpai. Loaʻa i kekahi mau mea i hiki ke komo i ka plasenta.

ʻO kaʻoiaʻiʻo, i ka wā e hoʻohana ai i ka hāʻule o ka maka, ua kūpono ka hoʻouluʻana o ka systemic i nā liʻiliʻi liʻiliʻi. Eia naʻe, ʻo ka methyl ethyl pyridinol kahi waiwai ikaika e pili pono ana i nā kaʻina metabola i loko o ke kino.

Hoʻokumu ka pāpā ma ka hoʻohana ʻana i ka lāʻau lapaʻau ma muli o ka nele o nā ʻike kūpono i ka hopena o kāna hoʻohana ʻana, ʻoiai, ma ka maoli, ʻaʻohe loiloi e hana ʻia ma nā wahine hāpai. No laila, ʻoiai he lāʻau lapaʻau ka mea, he hoʻohana i kona hana no ka mālama ʻana ma ke ʻano o ke kauka.

Retener macular degeneration - hana me ka lapaʻau ʻana kanaka a me ka lāʻau lapaʻau e wehewehe ʻia i kēia ʻatikala.

Kamaliʻi liʻiliʻi

E pili ana i ka mālama ʻana o nā keiki, ua hoʻokaʻawale ka ʻōlelo aʻo i nā makahiki i nā makahiki 18 - ma mua o ka mea, ʻaʻole ʻōlelo ʻia e mālama i nā keiki. Eia nō naʻe, aia mau kekahi mea hana i ka mea i pili kēia kakuhi ma muli o ka nele o nā hopena kūpono loa ma ka hoʻohana ʻana i ka lāʻau.

E heluhelu hou e pili ana i ka maka o Dexamethasone ma ka loulou.

Ma ka hoʻomaʻamaʻa, hoʻomaikaʻi pinepine nā keiki i ka Emoxipine a hiki i nā keiki hou, no ka mea, ʻaʻole i noho ka hoʻohana ʻana o nā keiki kūpono no kekahi mau ala i nā maka.

ʻO nā ʻōhua kūpono e hōʻino ʻia e ka lāʻau

Hoʻomaopopo nā loiloi hoʻomanawanui e hōʻomaʻamaʻa maikaʻi ʻia ka lāʻau. I nā hihia lohi, hiki i nā mea leʻaleʻa i ke ʻano o nā hopena alerine i hiki ke hoʻopau: puhi, ʻeha, ʻulaʻula, nā lacrimation.

I ka hihia o ka hoʻohana pū ʻana me nā lāʻau lapaʻau ʻē aʻe, e hōʻike ʻia e hoʻohana i ka Methylethylpyridinol hope loa, ma hope o ka liʻiliʻi he 15 mau minuke. mahope iho o ka noi ana aku i ka laau hope.

E pili ana i ka hāʻule no ka maka o Tsiprolet i kākau ma ka ʻatikala.

E like me nā analogues o ka lāʻau lapaʻau, hiki iā Emoxy-optic, Emoxipin-AKOS, hiki iā Emoxibel ke hoʻohana ʻia.

He lāʻau maikaʻi loa kēia lāʻau lapaʻau e hiki ke hoʻopilikia maikaʻi i nā kaʻina metabolic i loko o nā kiko o ka maka. No laila, ʻo kona hoʻohana ʻana no nā kumu therapeutic a me prophylactic e hiki ke hōʻoia i ke alo o kekahi mau pathologies, me ka hoʻoweliweli ʻana i kā lākou ulu ʻana.

ʻOiai ka mea pono o ka lāʻau lapaʻau ke kumu o ka hōʻike ākea ʻana, pono e hoʻohana ʻia ka hoʻohana ʻana a lawe ʻia ma lalo o ka nānā ʻana o kahi ophthalmologist.

E heluhelu pū e pili ana i nā lāʻau lapaʻau e like me ka ciprofloxacin i waiho i ka waihona.

E hoʻokuʻu i ke ʻano a me ka ʻano

Ka puka helu - ka ʻaina: ʻaina, hoʻonaninani a ʻole ka wai melemele, 1 ml kēlā me kēia mau pahu piha o ke aniani o ka pona a me ke aniani paha me kahi papa kūʻē o ka hydrolysis o HGA1, i loko o kahi pahu pahu pahu o 5 a 10 mau ʻūpato piha i piha me ka ʻāwili ampoule. ʻaʻole i hoʻokomo ʻia ka scarifier me ke kani a i ʻole kahi kuli) a i ʻole nā ​​mea hoʻonani āpau 1-2 mau o nā ampoules a me nā ʻōlelo no ka hoʻohana ʻana i ka Methylethylpyridinol, ka pāwili no nā hale maʻi - ma kahi pūpū pepa o 4, 5, 10, 50 a 100 mau pūʻulu contour pack i ka 5 hue.

Ke kūmole o 1 ml o ka hoʻonā:

• mea hoʻonaʻauao: methylethylpyridinol (ma ke ʻano o ka hydrochloride) - 10 mg,
• nā mea kōkua: 0.1 M hoʻonāʻana o ka wai hydrochloric, wai no ka injection.

Lapaʻau lāʻau

ʻO Methylethylpyridinol he antioxidant, kahi mea pale i nā hana radical manuahi.

Loaʻa ia he hopena maikaʻi i ka ʻōnaehana coagulation o ke koko: e hōʻemi ana i ka mea aneʻi o ke koko, e hoʻolōʻihi i ka manawa o ka hoʻokūkū, a ke pale aku nei i ka hui platelet. Hoʻopaʻa ʻo ia i nā membran o nā pili koko ʻulaʻula a me nā pū moku o ke koko, hoʻonui i ka pale ʻana o nā ʻāpana ololi i nā hemolysis a me ka trauma mekanika.

Hoʻonui i nā mea i loaʻa i ka nukila autclic i ka platelets (cyclic adenosine monophosphate a me ke cyclic guanosine monophosphate), hoʻoemi i ka hiʻolima o ka paia vascular, hoʻolaha i ka hoʻokuʻi ʻana o nā hemorrhages, a loaʻa nā hana fibrinolytic.

Hoʻoulu i ka microcirculation i loko o nā lau o ka maka, me nā kīʻaha o ka retina. Loaʻa ia i ka hopena retinoprotective, mālama i ka retina mai nā hopena ʻino o ka mālamalama kiʻekiʻe-ʻoi aku.

Nā hōʻailona no ka hoʻohana ʻana

Hoʻohana ʻia ka Methylethylpyridinol ma ke ʻano o ka lāʻau paʻakikī i nā maʻi / nā maʻi i kēia manawa.

• nā maʻi dystrophic o ka kornea,
• nā ʻōpū intraocular a me ka subconjunctival o nā ʻano ʻano kumu,
• ka waena, a me nā peripheral chororetinal dystrophy,
• ka lahuiʻeha (me ka maʻi maʻi maʻi),
• ka hoʻopau kai makiosclerotic (form dry),
• he thrombosis o waena o ka veina a i kona mau lala,
• huina Onaopia,
• Hoʻomaʻamaʻa ke 2 a ʻoi aku kahi hōʻeha,
• detachment o ka choroid i ka wā postoperative ma hope o ka hana no ka glaucoma,
• ka pōʻino o ka maka me ka mālamalama kiʻekiʻe-ʻokoʻa (ka wili o ka laser i ka wā o ka hoʻoulu ʻana ʻana) - i ka mālama ʻana a me ka pale ʻana.

Methylethylpyridinol, nā ʻōlelo e hoʻohana ai i ka: ʻano a me ke ʻano

Hoʻolālā ʻia ke ʻano o ka inikua Methylethylpyridinol e parabulbarno (s / b) a i ʻole (c / c). Hoʻohana ʻia ka lāʻau lapaʻau ma ke ʻano o ka hopena paʻakikī.

Nā mea hoʻoponopono lula kumu:

• Nā maʻi dystrophic o ka kornea: s / c 0.5 ml i hoʻokahi manawa i ka lā i kahi papa o 10-30 lā,
• nā hemorrhages intraocular a me subconjunctival o nā ʻano kumu: s / c a i ʻole p / b 0.5 ml i hoʻokahi lā i ka lā no 10-15 mau lā,
• ka waena, a me ka peripheral chstroretinal dystrophy, maloʻo ke kaomiclerotic macular degeneration: 0.5 ml p / b hoʻokahi lā no ka lā 10-15,
• e hoʻonāukiuki i ka vein waena o ka retina a me kona mau lālā: n / a he 0.5 ml i hoʻokahi manawa i ka lā i kahi papa o 10-15 lā,
• myopia paʻakikī: p / b 0,5 ml hoʻokahi manawa i ka lā no 10-30 mau lā, inā pono 2-3 manawa i ka makahiki, e hoʻokipa hou i nā papa,
• nā hōʻeha a me ka puhi ʻana i ka hopena o ka hopena o ka pae 2: p / b 0.5 ml 1 manawa i ka lā no 10-15 lā,
• detachment o ka choroid i ka wā postoperative ma hope o ka loaʻa ʻana o ka hoʻomaʻamaʻa glaucoma: s / c a i ʻole p / b, 0.5-1 ml i kēlā me kēia lā, ʻo ka papa o ka mālamaʻana he 10 injections.
• ka pale ʻana i ka wā o ka coagulation laser (me ka hoʻopau ʻana a me ka luku ʻana i nā koikoi o nā ʻoi ʻana): 0.5-1 ml p / b 24 mau hola a me 1 h ma mua o ka coagulation, a laila 0.5 ml hoʻokahi i ka lā i kēlā me kēia no 2-10 mau lā.

Nā hopena hopena

• nā kūloko kūloko: ke kuni, hōʻeha, ka hyperemia, ka ʻeha, ka hoʻopili ʻana i nā kiko paraorbital (ʻaʻole pono ka lawelawe kūikawā, hoʻopau i ke kūʻokoʻa)
• nā maʻi kūlohelohe: ka ʻolima, ka kele ʻana o ka ʻili, edema, hyperemia,
• mai nā ʻōnaehana oʻilihune: lūlū, ka pōkole o ka pōkole
• mai ka ʻōnaehana cardiovascular: nā pehu ʻili, ke piʻi ʻana o ke koko.

Hoʻohui nūhou

ʻAʻole kue ka Methyl ethyl pyridinol me nā lāʻau lapaʻau ʻē aʻe, no laila ke pāpā ʻia i ka hoʻohui ʻana iā ia i loko o ka syringe like me nā lāʻau ʻē aʻe.

ʻO nā hui o Methylethylpyridinol nā: Vixipin, Cardioxypine, Methylethylpyridinol-Eskom, Emoxy-optician, Emoxibel, Emoxipin, Emoxipin-AKOS, etc.

Nā ʻike e pili ana i ka Methylethylpyridinol

ʻO nā hōʻike e pili ana i ka methylethylpyridinol liʻiliʻi, akā maikaʻi. Ua hōʻike ʻia ke lāʻau lapaʻau i ka hana ʻoi kiʻekiʻe, ʻolua.Eia naʻe, e like me nā mea maʻi, ʻoi aku ka maʻalahi o ka hoʻohana ʻana i nā lāʻau lapaʻau me ka waiwai ikaika no loko o ke ʻano o ka hāʻule ʻana o ka maka.

Hoʻohana pinepine ʻia ka Methylethylpyridinol no nā maʻi ophthalmological like pū, a me nā maʻi no ka neʻe ʻana a me nā pathology cardiovascular.

Methylethylpyridinol: nā kumukūʻai i nā lāʻau lapaʻau pūnaewele

Mawaena Methylethylpyridinol 10 mg / ml no 1 ml 10 mau pā.

ʻO ka hopena ʻo Methylethylpyridinol d / i. 10 mg / ml amp. 1ml No. 10 ELLARA

Hoʻonaʻauao: Rostov State Medical University, kūikawā "General Medicine".

Hōʻike nui ʻia ka ʻike e pili ana i ka lāʻau lapaʻau, i hoʻolako ʻia no ka hana ʻike a ʻaʻole hoʻololi i nā ʻōlelo aʻoaʻo. Hoʻopilikia ka lāʻau-pono iā ia ke olakino!

ʻO ka mea ma mua, ʻo ia ka hana ʻana i ke kino me ka oxygen. Akā, ua kolohe ʻole kēia ʻike. Ua hōʻoia nā ʻepekemaʻepekema i ka yawning, hoʻokaʻawale kahi kanaka i ka lolo a hoʻomaikaʻi i ka hana ʻana.

ʻAʻohe haʻahaʻa i ka mea i hoʻonaʻauao ʻia i nā maʻi lolo. Hāʻawi ka hana naʻauao i ke kūkulu ʻana i kahi kikoʻī hou aku e uku aku ai i ka poʻe maʻi.

ʻO ka nui ka mea ikaika loa o ko mākou kino. ʻO 1.5 ka paona nui ko 1.5 kg.

Inā hāʻule ʻoe mai kahi hoki, ʻoi aku ka ʻoi aku o kou ʻāʻī ma mua o ka hāʻule ʻana mai kahi lio. Mai hoʻāʻo wale e hōʻole i kēia ʻōlelo.

ʻO James Harrison kahi kanaka 74 o kāna makahiki o Australia, ua lilo ia i mea honi koko ma kahi o 1,000 mau manawa. Loaʻa iā ia kekahi ʻano koko nui, nā antibodies o nā mea kōkua i nā pēpē hou me ke anemia koʻikoʻi. No laila, ua mālama ʻo Australia i kahi miliona miliona keiki.

Ua hana ʻia ka vibrator mua i ka kenekulia 19. Ua hana ʻo ia ma ka mokuahi kahi i manaʻo ʻia no ka mālama ʻana i ka hysteria wahine.

Ke "holo" nei ke koko o ke kanaka ma o nā moku ma lalo o ka pīhoihoi nui, a inā i uaki ʻia kona kūpaʻa, hiki iā ia ke pana a 10 mau mika.

Ua hana ʻia nā ʻepekema mai Oxford University i kahi ʻano o nā haʻawina, i ka wā i hele ai lākou i ka hopena o ka vegetarianism hiki ke hoʻopōʻino i ka lolo o ke kanaka, ʻoiai e hala ana i ka emi ʻana o kāna ʻano. No laila, ʻōlelo ʻo nā kānaka ʻepekema i ka haʻalele ʻole ʻana i ka iʻa a me ka ʻai i kā lākou meaʻai.

I 5% o nā mea maʻi, ʻo ka clomipramine antidepressant e hōʻeha i kahi orgasm.

I ka wā e ola ai ka mea, ʻo ka mea maʻamau e hoʻomālamalama ma mua o ʻelua mau loko wai nui.

I ka wā hana, hoʻonui ka lolo i ka nui o ka ikehu me ka umauma māmā 10-watt. No laila ʻo ke kiʻi o ka pīpī mālamalama ma luna o kou poʻo i ka manawa o ka hiʻohiʻona o kahi manaʻo kupanaha ʻaʻole loa e mamao loa i ka ʻoiaʻiʻo.

Ua ʻike hou ʻia nā Dentist. I ka hope o ke kenekulia 19, ua hana ia i kahi mea kāhiko maʻamau e huki i nā niho maʻi.

ʻO ka lāʻau lapaʻau maikaʻi loa "Viagra" i hana mua ʻia no ka mālama ʻana i ka hypertension arterial.

Hiki i ka hapa nui o nā wahine ke loaʻa ka leʻaleʻa hou aʻe i ka noʻonoʻo ʻana i ko lākou kino nani i ke aniani ma mua o ka moekolohe. No laila, ʻo nā wahine, e hoʻoikaika i ka kūlike.

Ua kūʻai mua ʻia nā ʻano lāʻau he nui nā hua lāʻau. ʻO Heroin, no ka laʻana, ua kūʻai ʻia mua ʻo ia ke ʻano o ka lāʻau lapaʻau. A aʻo ka niu o nā niu e nā kauka ma ke ʻano he hanu a he mea e hoʻonui ai i ka hoʻomanawanui.

ʻO ka polyoxidonium e pili ana i ka lāʻau lapaʻau immunomodulatory. Hana ia i kekahi mau wahi o ka ʻōnaehana pale, a laila e kōkua ana i ka hoʻonui ʻia ʻana o ka.

Lapaʻau lāʻau

Ka helu ʻāpana - 5.2 lita. ʻO ka pau ʻana he hapalua-ola ke 18 mau minuke. ʻO ka huina piha he 0.2 l / min. Hoʻopili i ka puʻuwai. Ke hoʻopio ʻia nei e nā ʻōpū.

Ma kahi ʻāpana o ka ulia pōpilikia:

• ʻO ka subconjunctival a me nā hana hemolele e pili ana i nā ʻano ʻōiwi like ʻole.
• ʻO Angioretinopathy (me ka helu maʻi o ka maʻi maʻi),
• Nā kikowaena a me ka hoʻōla waena o ka peripheral.
• ʻO ka thrombosis o ke koena retinal central a me kāna mau lālā.
• Nā ʻōnoʻa o ka myopia
• Hōʻea ka Angiosclerotic macular degeneration (puka maloʻo),
• Detachment o ka choroid i ka wā postoperative ma hope o ka hana no ka glaucoma,
• Nā maʻi dystrophic o ka kōmato,
• ʻAi nā hōʻeha, hoʻopau i ka kornea,
• Hoʻomaʻamaʻa a me ka pale ʻana i nā leʻaka o ka maka me ka malamalama nui (kulu i ka lā, ka radiation o ka laser i ka wā o ka coagulation laser).

ʻLoe a me ke kākele

Hoʻohana ʻia ka lāʻau lapaʻau ma ke ʻano o ka hopena paʻakikī.

Me nā subconjunctival a me nā hemorrhages intraocular o nā ʻano hānau - subconjunctival a i ʻole parabulbar 0,5 ml hoʻokahi i ka lā. ʻO ke kumu o ka mālamaʻana he 10-15 lā.

Me ka angioretinopathy (e komo pū ana me ka maʻi maʻi) - parabulbarno 0,5 ml 1 manawa i kēlā me kēia lā. ʻO ke ala no ka mālamaʻana he 10 mau lā.

Me ka kikowaena waena a me ka peripheral chstroretinal dystrophy, a me ka antisclerotic macular degeneration (puka maloʻo) - parabulbar 0,5 ml hoʻokahi i ka lā. ʻO ke kumu o ka mālamaʻana he 10-15 lā.

Me ka thrombosis o ka retinal urinal i waena a me kāna mau lālā - parabulbarno 0,5 ml hoʻokahi i ka lā. ʻO ke kumu o ka mālamaʻana he 10-15 lā.

I kaʻuʻōpili paʻakikī - parabulbarno 0,5 ml hoʻokahi lā i ka lā. ʻO ka papa o ka mālamaʻana he 10-30 mau lā, hiki nō ke hoʻopaʻi hou i ka papa i nā manawa he 2-3 i ka makahiki.

Me ka wehe ʻana o ka choroid i nā mea maʻi me ka glaucoma i ka wā postoperative - parabulbar a i ʻole subconjunctival 0.5-1.0 ml hoʻokahi i kēlā me kēia 2 mau lā. ʻO ke ala e mālama ai he 10 injections.

No nā mea hōʻeha a me ka puhi ʻana o ka hopena o ka ʻiʻo o ka pae puka - parabulbarno 0,5 ml hoʻokahi i ka lā. ʻO ke kumu o ka mālamaʻana he 10-15 inikini.

Me nā maʻi dystrophic o ka kornea - subconjunctival 0,5 ml hoʻokahi i ka lā. ʻO ke kumu o ka mālamaʻana he 10-30 mau lā.

No ka pale ʻana i ka retina i ka wā coagulation laser (me ka hoʻopau ʻana a me ka luku ʻana i ka koikoi o nā kani ʻana), 0.5-1.0 ml o ka hopena o 1% (5-10 mg) parabulbarly 24 mau hola a me 1 hola ma mua o ka coagulation, a laila ma nā dosis like ( ʻO 0.5 ml o ka hopena o 1%) ka manawa i ka lā no 2-10 lā.

Ke keu

I ka hihia o kahi overdose, hiki i ka nui o ke koʻikoʻi o nā hopena kūlike ona o ka hopena o ka lāʻau hiki ke hoʻopau.

Nā hōʻailona: hoʻonui i ke koko, ke kō a nā kahe, ke poʻo, ka ʻeha o ka naʻau, ke aloha, ka ʻoluʻolu ma ka wahi epigastric. Hiki paha nā maʻi koko.

Hoʻolālā: hoʻihoʻi i nā lāʻau, maʻi therapy, ʻaʻohe antidote kikoʻī.

Nā ʻōlelo kikoʻī

Pono e mālama ʻia ka lāʻau me ka methylethylpyridinol ma lalo o ka kaohi o ke koko a me ka hoʻopā koko.

Hoʻokomo i ka hiki ke alakaʻi i nā kaʻa a hana me nā mīkini

Me ka hoʻomohala ʻana o ka hiamoe, pono ia e pale i ke kaʻa ʻana i nā kaʻa a me nā ʻano hana ʻē aʻe, e makaʻala hoʻi i ka wā e hana ai i nā hana ʻonaʻawaʻawa e pono ai ka piʻi ʻana o ka nānā a me ka wikiwiki o ka hopena psychomotor.

ʻO ka wehewehe ʻana o ka waiwai ikaika Methylethylpyridinol / Methylaethylpiridinolum.

Paula C8H11NO, inoa lāʻau: 3-hydroxy-6-methyl-2-ethylpyridine hydrochloride.
ʻĀpana hoʻolaʻa: nā lāʻau lapaʻau hematotropic / antiplatelet agents, metabolism / antihypoxants a me antioxidants, nā mea kanu organotropic / cardiovascular agents / angioprotectors a me nā microcirculation pololei, nā mea kanu organotropic / ophthalmic āpana.
Hoʻolaha hana: antihypoxic, antiaggregational, antioxidant, angioprotective, retinoprotective.

ʻO nā waiwai Pharmacological

ʻO Methylethylpyridinol kahi angioprotector, antihypoxant a me antioxidant, he mau mea retinoprotective. Hoʻopili ke Methylethylpyridinol i nā hana kūlohelohe manuahi. Hoʻomau nā Methylethylpyridinol i nā membrane cell. Hoʻoulu ʻo Methylethylpyridinol i ka hoʻokōkōkiko. ʻO ka Methyl etyl pyridinol e hōʻemi i ka hoʻohui platelet a me ka nānāʻana i ke koko, e hōʻemi i ka index coagulation holoʻokoʻa, e hoʻolōʻihi i ka manawa o ka coagulation koko, hoʻonui i nā kiko o ka nucleotides cyclic (cyclic guanidine monophosphate a me ka cyclic adenosine monophosphate) i loko o ka lolo a me nā platelets. Hoʻohana ka Methylethylpyridinol i ka hana fibrinolytic, hoʻoikaika i ka paia vascular, hōʻemi i ka hoʻokele o ka pā vascular a me ka hopena o ka hemorrhage, hoʻolaha ia i ka hoʻoulu ʻana o nā hemorrhages. Mālama ka Methylethylpyridinol i nā membran me nā kīʻaha koko ʻōpiopio a me nā ʻāpana moku koko, hoʻonui i ka pale ʻana o nā ʻāpana ololi i nā hemolysis a me ka hōʻeha ʻo ka mīkini. Hoʻonui ka Methylethylpyridinol i ka hana o nā enzyme antioxidant, ke kāohi pono ʻole i ka oxidation free radical lipids o biomembranes. Loaʻa ka Methylethylpyridinol i kahi hopena antitoxic, hoʻopaʻa i ka cytochrome P-450. I nā kūlana koʻikoʻi, e hele pū me ka hypoxia a me ka hoʻonui ʻia o ka lipid peroxidation, methylethylpyridinol e hoʻohālikelike i nā hana bioenergy. Ma kahi ulia pōpilikia ischemic akene, methylethylpyridinol e hōʻemi i ka nui o nā hōʻike neurological, hoʻonui i ka pale kino i ka ischemia a me hypoxia. I loko o nā hihia o ka ulia cerebrovascular (hemorrhagic a ischemic), hāʻawi a me ka methylethylpyridinol i ke hoʻoponopono ʻana i ka hana autonomic, hoʻomaikaʻi i nā hana mnemonic, a hoʻomaʻamaʻa i ka hoʻihoʻi ʻana o ka hana naʻau integrative. ʻO ka Methylethylpyridinol ke hōʻemi i ka hoʻokumuʻana o ka triglycerides, he hopena lipid-hoʻemi. Hoʻololi ka Methylethylpyridinol i nā kīʻaha koko o ka puʻuwai, hōʻemi i ka pōʻino o ka ischemic i ka myocardium, hoʻomaikaʻi i ka hana o ke kaʻi o ka conduction o ka puʻuwai a me ka paʻa ʻana o ka naʻau. Hoʻopili ka Methylethylpyridinol i ka nui o ka makaʻala o ka nekrosis, e hoʻomaikaʻi ana i nā kaʻina reparative, normalize i ka metabolism o ka puʻuwai puʻukui i ka myocardial infarction. He hopena maikaʻi ka Methylethylpyridinol ma ke kahua o ka papa lāʻau o ka myocardial infarction, me ka hōʻemi ʻana i nā mea o ka pūpū puʻuwai hema ʻole. I ka hihia o ka hiki ʻole o ke kaʻe o ka leʻaleʻa, ʻike ka methylethylpyridinol i ka hoʻoponopono ʻana o ka ʻōnaehana redox. Me ke koko kiʻekiʻe, ʻo ka methyl ethyl pyridinol he hopena hypotensive. Mālama ka Methylethylpyridinol i ka retina i nā hopena poino o ka māmā kiʻekiʻe, e hoʻomaikaʻi i ka microcirculation maka, a kōkua i ka hoʻonā ʻana o nā hemorrhages intraocular.
Ke hoʻihoʻi ʻia i ka lua o ka conjunctival, methylethylpyridinol komo koke i nā ʻāpana o ka maka, kahi i waiho ʻia a hoʻoliili ʻia. ʻO ke kaemae o methylethylpyridinol i loko o nā kōpili o ka maka e ʻoi aku i ke koko. Hoʻohālikelike ia i nā protein plasma koko e pili ana i ka 42%. Me ka hoʻokele intravenous o ka methylethylpyridinol ma ke ʻano o 10 mg / kg, ua nānā ʻia kahi haʻahaʻa hapalua (18 mau minuke), e hōʻike ana i kahi kiʻekiʻe o ke kāpae ʻana o ka methylethylpyridinol mai ke koko. ʻO ka hoʻopau mau ʻana he mau minuke 0,041 mau minuke. E komo koke ka Methylethylpyridinol i loko o nā pupu a me nā hui, kahi i hoʻopiʻi ʻia a hoʻoneʻe. ʻO ka nui ʻike ka laha ʻana o ka methylethylpyridinol he 5.2 lita. ʻO ka huina piha o ka methylethylpyridinol he 214.8 ml / min. Loaʻa ʻelima mau metabolites, ka mea i hōʻike ʻia e nā huahana hoʻololi koulkihua a me ka hoʻohuli o ka methylethylpyridinol. Hoʻomili ka Methylethylpyridinol i loko o ka mōʻī. ʻO nā nui nui o 2-ethyl-6-methyl-3-hydroxypyridine-phosphate e ʻike i ka puʻuwai. ʻO nā Methyl etil pyridinol metabolites i hoʻopiliʻia e nā keiki. I nā kūlana pathological, no ka laʻana, me ka neʻe coronary, loli nā pharmacokinetics o ka methylethylpyridinol: e emi ana ka nui o ka excretion, ma muli o ka bioavailability o ka methylethylpyridinol, hoʻonui, ka manawa noho o ka methylethylpyridinol i ke kahe koko, he mea pono no ka hoʻi ʻana mai i ka depot, me ka ischemic myocardium.

ischemic stroke, hemorrhagic stroke in the recovery period, chronic cerebrovascular insufficiency, transient cerebrovascular accident, akibat a cerebrovascular and hemorrhagic and ischemic cerebrovascular accident, traumatic brain injury, postoperative period of epidural and subdural hematomas.
ka pale ʻana o ka maʻi reperfusion, kaila myocardial infarction, kaomi pectoris paʻa.
hemorrhage intraocular a me subconjunctival, hemorrhages i loko o ke keʻena anterior o ka maka, hemorrhages i ka sclera i ka poʻe ʻelemakule (komo pale ʻana), angioretinopathy (komo i ka angioretinopathy maʻi), keratitis dystrophic, angiosclerotic maculodystrophy (maina forma, thrombosis, thrombosis, ka wī kiko o ka retina a me kona mau lālā, ka dystrophy chorioretinal (e komo pū ana me ka dystrophy chorioretinal o ka atherosclerotic origin), palekana o ka kornea (i ka wā e kāʻā ʻia ai ʻo ia) x lente) a me ka retina mai ka ʻike i ke kukui nui (me ka coagulation laser, ka lā a me ka puhi ʻana o ka laser), nā maʻi dystrophic o ka kornea, nā hopena hoʻopiʻi o myopia, cataract (komo i ka pale ʻana o nā cataract ma nā kānaka ma luna o 40), trauma, ʻāʻī a me ka puhi ʻana o ka kornea, ka hopena ma hope o ka hoʻomaʻamaʻa ʻana. e pili ana i ka glaucoma me ka choroid detachment, ka hōʻea ʻana o nā maʻi ma nā maka.

Ke ʻano o ke hoʻohana ʻana o ka methylethylpyridinol a me nā kūlohelohe

Hoʻohana ʻia ka Methylethylpyridinol i nā intravenously, intramuscularly, subconjunctival, parabulbar, retrobulbar, hoʻokomo i ka lua o ka conjunctival.
I loko o ka puʻukū, ʻo ke kanu ʻana i ka 1 a hiki i ka hāʻule 2 (1% hoʻonā) 2 a i 3 mau manawa i ka lā, ʻo ka lōʻihi o ke ʻano o ka papa e hilinaʻi ʻia ana i ka maʻi o ka maʻi a hoʻoholo ʻia e ke kauka (maʻamau 3 a 30 mau lā), inā ua hoʻomanawanui iki ʻia ka lāʻau lapaʻau a ʻike ʻia nā hōʻailona. e hoʻomau i ka 6 mahina a i ʻole mau i ka 2 i 3 mau manawa i ka makahiki.
Hoʻokele ʻia ka Subconjunctival a parabulbar i hoʻokahi manawa a i kēlā me kēia lā. ʻO 0.2 - 0,5 ml o kahi hopena o 1% (2 - 5 mg) e lawelawe ana i ka subconjungtly, 0,5 - 1 ml o kahi hopena o 1% (5 - 10 mg) e lawelawe ʻia ana, ʻo ka lōʻihi o 10 - 30 lā, hiki nō ke kuhi papa, inā pono, 2 a 3 mau manawa i ka makahiki. Inā kūpono, ʻo ka retrobulbar 0.5 i ka 1 ml o ka hopena o 1% e mālama ʻia i hoʻokahi manawa i ka lā no 10 a 15 mau lā. I ka wā e hoʻoulu ʻia ai ka laser (me ka hoʻoneʻe ʻana a i ka palena ʻana o ka ʻōpū), ʻo ka retrobulbar a i ʻole ka parabulbar 0,5 i 1 ml o 1% hoʻonā i hoʻokahi lā lā no 2 a 10 lā.
ʻO Angioretinopathy (e pili ana i ka angetinetinopathy diabetes): 0.5 ml parabulbarno (10 mg / ml methylethylpyridinol) hoʻokahi manawa i ka lā, ʻo ka papa o ka lapaʻau he 10 lā. ʻO nā haʻahaʻa subconjunctival a me intraocular o nā ʻano ʻōmole: parabulbarno a i ʻole subconjunctival 0,5 ml (10 mg / ml methylethylpyridinol hopena) hoʻokahi manawa i ka lā, ʻo ke ʻano o ka mālama ʻana he 10-15 lā. ʻO ka dystrophy chorioretinal chrisoretinal central and peripheral, angiosclerotic macular degeneration (ʻano ala): 0.5 ml parabulbarno (methylethylpyridinol solution 10 mg / ml) hoʻokahi manawa i ka lā, ʻo ka papa o ka mālama ʻana he 10-15 lā. ʻO ka myopia i hoʻopiʻi ʻia: 0.5 ml parabulbarno (methylethylpyridinol solution 10 mg / ml) hoʻokahi lā i ka lā, ʻo ke ʻano o ka mālama ʻana he 10-30 mau lā, he papa hana e hana hou ʻia 2 a 3 mau manawa i ka makahiki. ʻO ka trombosis o ka vein waena o ka retina a me kāna mau lālā: 0.5 ml parabulbarno (methylethylpyridinol solution 10 mg / ml) hoʻokahi manawa i ka lā, ʻo ka papa o ka lapaʻau ka 10-15 lā. Detachment o ka choroid i nā mea maʻi me ka glaucoma i ka wā postoperative: subconjunctival a parabulbar 0,5 i 1.0 ml (10 mg / ml methylethylpyridinol) hoʻokahi manawa i kēlā me kēia 2 mau lā, ʻo ke ʻano o ka lapaʻau he 10 injections. Nā maʻi dystrophic o ka kornea: subconjunctival 0.5 ml (10 mg / ml methylethylpyridinol) hoʻokahi manawa i ka lā, ʻo ka papa o ka maʻi he 10-30 mau lā. ʻO nā hōʻeha a me ka puhi o ka ʻiʻo o ka hopena o ka lua: 0.5 ml parabulbarno (methylethylpyridinol solution 10 mg / ml) hoʻokahi lā i kēlā lā i kēia lā, ʻo ka papa o ka lapaʻau ka 10-15 injections.
injected intravenously (20-40 mau minuke i ka minuke), 20-30 ml o kahi kūmole 3% (600-900 mg) 1 a 3 mau manawa i kahi lā no 5-15 mau lā, e like me nā hōʻike a me ke ʻano o ka maʻi (pre-diluted with methyl ethyl pyridinol 200 ml o kahi hopena o 5% o dextrose a i ʻole he 0.9% hopena o ka sodium klorida), a laila huli lākou i kahi intramuscular injection - 3 a 5 ml o kahi hopena 3% 2 i 3 mau lā i ka lā no 10 a 30 mau lā.
lawelawe ia intravenously dropwise (20-30 mau minuke) i kēlā me kēia lā o 5-10 mg / kg no 10-12 mau lā, a laila e hoʻololi i ka intramuscular injection o 2-10 ml (kūleʻa me ka hoʻokolohua o 30 mg / ml) (60-300 mg ) 2 a 3 mau manawa i kahi lā no 10 a 30 lā.
Hoʻohana ʻia ka Methylethylpyridinol ma ke ʻano o ka mālama paʻakikī.
Pono e mālama ʻia me ka methyl etil pyridinol ma lalo o ke kaʻi o ka hoʻokalakupua a me nā ʻōnaehana anticoagulation o ke koko a me ke koko.
Inā pono e hoʻohana i ka methylethylpyridinol ma ke ʻano o ka hāʻule ʻana o ka maka me nā mea lapaʻau ʻē aʻe ma ke ʻano o ka hāʻule ʻana o ka maka, ua hoʻopau koke ʻia ka methylethylpyridinol ma hope o ka hoʻomoʻa piha ʻana o ka lāʻau mua (ma ka liʻiliʻi loa 15 mau minuke).
I ka wā o ka ʻoihana me ka methyl etil pyridinol, ka mea i ka lewa i ka hiamoe, a hoʻohaʻahaʻa i ke koko, e kuhikuhi ʻia e hōʻohi i ka hana ʻana i nā hana e pili ana i ka hopena o ka hopena e koi ai i ka neʻe nui o ka nānā a me ka wikiwiki o ka hopena psychomotor (me ka kaʻa o nā kaʻa, nā hana hana).

ʻŌpū a me ka lactation

ʻO ka hoʻohana ʻana o ka methylethylpyridinol i ka wā o ka hapai a me ka lactation, no ka mea, ʻaʻohe i kūpono a me nā hoʻokele pono ʻana i nā palekana o ka methylethylpyridinol i ka wā hapai a me ka lactation. I ka wā o ka mālama ʻana me ka methyl ethyl pyridinol, pono e hooki ʻia ka mālama ʻana i ka umauma.